Legal Representation
Attorney
Kisuk Lee
USPTO Deadlines
Next Deadline
1890 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250225)
Due Date
February 25, 2031
Grace Period Ends
August 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 27, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 11, 2025 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Sep 7, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 7, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| May 25, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 25, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 25, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 7, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 7, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 1, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 16, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 13, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 13, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 13, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 13, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 24, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Aug 7, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Aug 7, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| May 7, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 7, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 7, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 26, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 26, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 26, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 26, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 26, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 26, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 25, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Oct 2, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Oct 2, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 20, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 19, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 12, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 14, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 10, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 9, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Cell separation research services; development of cell therapy products; drug discovery services; research to develop new products in the field of oncology and precision medicine, cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; pharmaceutical drug development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical drug development services; consultancy pertaining to pharmacology; medicine research; stem cell research services; DNA analysis for scientific research purposes; consultation and providing information in the field of biomedicine research and development; research relating to crude drugs; biochemical analysis; clinical research in the field of medicine; scientific research services for medical purposes
Additional Information
Design Mark
The mark consists of the design of a flower containing two concentric circles. each having a border of a DNA double helix, to the left of the wording "BLUEWAVE BIO" above the wording "PRECISION LABORATORY SERVICES".
Pseudo Mark
BLUE WAVE BIO PRECISION LABORATORY SERVICE
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIO and LABORATORY SERVICES